Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen
NCT05088226
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Blood Stem Cell Transplantation
Interventions
DRUG:
Ruxolitinib combined with Chidamide.
Sponsor
Chinese PLA General Hospital